Literature DB >> 31520995

MicroRNA-27a alleviates IL-1β-induced inflammatory response and articular cartilage degradation via TLR4/NF-κB signaling pathway in articular chondrocytes.

Wen-Jun Qiu1, Ming-Ze Xu1, Xiao-Dong Zhu1, Yun-Han Ji2.   

Abstract

Osteoarthritis (OA) is a common disease of the articular cartilage, and inflammatory response and articular cartilage degradation have been implicated in the pathogenesis of OA. In recent years, microRNAs (miRNAs) have been potentially involved in the pathogenesis of OA. However, little is known about the role of miRNAs in the inflammatory response and articular cartilage degradation in OA and the underlying molecular mechanism. In the present study, we analyze miRNA profiles in the articular tissues from OA patients using microarray. miR-27a has attracted considerable interest for its suppressive effects on inflammation. Subsequently, the expression levels of miR-27a were validated in the articular tissues of OA patients and IL-1β-stimulated chondrocytes. Using this IL-1β-induced chondrocyte injury model, we found that upregulation of miR-27a suppressed articular cartilage degradation, the reactive oxygen species (ROS) production and inflammatory response as reflected by reductions in pro-inflammatory cytokines, including interleukin (IL)-6 and IL-8 and tumor necrosis factor (TNF)-α. Moreover, toll-like receptor 4 (TLR4), one upstream molecule of NF-κB signaling pathway, was identified as a direct target of miR-27a in chondrocytes. Furthermore, it was demonstrated that overexpression of TLR4 by pcDNA-TLR4 markedly abrogated the inhibitory effects of miR-27a on the inflammatory response and the degeneration of articular cartilage induced by IL-1β. Our findings suggest that miR-27a may be considered as a potential therapeutic target in the treatment of OA.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Articular cartilage degradation; Inflammatory response; MicroRNA-27a; Osteoarthritis; TLR4/NF-κB signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 31520995     DOI: 10.1016/j.intimp.2019.105839

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  The non-coding RNA interactome in joint health and disease.

Authors:  Shabana A Ali; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2021-09-29       Impact factor: 20.543

2.  Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation.

Authors:  Ling Peng; Li Wen; Qing-Feng Shi; Feng Gao; Bin Huang; Jie Meng; Cheng-Ping Hu; Chang-Ming Wang
Journal:  Cell Death Dis       Date:  2020-11-13       Impact factor: 8.469

3.  Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression.

Authors:  Yumei Cao; Su'an Tang; Xiaoyu Nie; Zuoqing Zhou; Guangfeng Ruan; Weiyu Han; Zhaohua Zhu; Changhai Ding
Journal:  EBioMedicine       Date:  2021-03-11       Impact factor: 8.143

4.  Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis.

Authors:  Junjie Li; Lijia Peng; Wenya Bai; Peihua Peng; Wendong Chen; Wei Yang; Jianlin Shao
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-22       Impact factor: 2.570

5.  Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis.

Authors:  Yuanjie Li; Wen Song; Yue Tong; Xia Zhang; Jianjun Zhao; Xiaojuan Gao; Jingjiao Yong; Hanqing Wang
Journal:  J Neuroinflammation       Date:  2021-01-05       Impact factor: 8.322

Review 6.  Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.

Authors:  Hui Kong; Ming-Li Sun; Xin-An Zhang; Xue-Qiang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-15

7.  Similarities and differences between rat and mouse chondrocyte gene expression induced by IL-1β.

Authors:  Dao-Fang Ding; Yan Xue; Jun-Peng Zhang; Zeng-Qiao Zhang; Wen-Yao Li; Yue-Long Cao; Jian-Guang Xu
Journal:  J Orthop Surg Res       Date:  2022-02-04       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.